Effects of combine training on Serum Adropin and nitric oxide in stage-1 hypertensive postmenopausal wome
Not Applicable
- Conditions
- Condition 1: Hypertention. Condition 2: Hypertension.Hypertensive heart diseaseHypertensive heart disease with heart failure
- Registration Number
- IRCT20180430039485N1
- Lead Sponsor
- Kharazmi University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 24
Inclusion Criteria
Systolic and diastolic blood pressure >140/90 and<159/99
Menopausal women
No any participant to regular exercise training for 1 year
Exclusion Criteria
Functional limitations (such as osteoarthritis)
Systolic blood pressure more than 160 and diastolic more than 100 mm Hg
Body mass index >28
Diabetes and obesity
Cardiovascular disease
Liver and kidney disease
mental disease
Cessation of drug use during the study
No use hormone therapy, no smoking and no use alcohol
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum adropin level. Timepoint: pre study and after 8 weeks. Method of measurement: adropin kit.;Serum nitric oxide level. Timepoint: pre study and after 8 weeks. Method of measurement: nitric oxide kit.
- Secondary Outcome Measures
Name Time Method